Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness.

J. M. Arencibia, A. V. Schally, M. Krupa, A. M. Bajo, A. Nagy, K. Szepeshazi, A. Plonowski

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness.'. Together they form a unique fingerprint.

Medicine & Life Sciences